COVID-19 TEST TERMS AND CONDITIONS

Overview

  1. This agreement (“This Document”) dictates the Terms and Conditions for the conduction of COVID-19 Testing Service ("Testing Service") through Molecular Matrix, Inc. and its personnel, employees and affiliates, to the Test Recipient.

  2. This Document, in addition to the agreements made by the Test Recipient as part of the registration process (electronic registration form) for receiving COVID-19 Testing, comprise the entire agreement between the parties.

  3. This Document supersedes all prior agreements, understandings, representations and all forms of prior communication between Molecular Matrix, Inc. and the Test Recipient.

  4. I am the Test Recipient named below or I am the parent or legal guardian (if the Test Recipient is a minor or dependent) of the Test Recipient named below.

 

COVID-19 Testing

  1. Molecular Matrix, Inc. shall provide COVID-19 Testing Services to the Test Recipient in accordance with This Document.

  2. Test Samples will be collected through the Test Recipient’s self swab, which will be supervised by trained Molecular Matrix, Inc. staff.

  3. The purpose of the COVID-19 Testing Service is to determine whether the presence of COVID-19 novel coronavirus can be detected in the sample collected from the Test Recipient at the time of testing (Test Results). No other test results or information are expected to be determined or supplied.

  4. It is the responsibility of Test Recipient to determine how COVID-19 services are covered by Test Recipient's health care insurer.

  5. While an estimated timeframe for receiving Testing Service results is provided, unknown factors, including high demand for COVID-19 testing, could result in delays in the delivery of results. The time between when a Test Recipient is tested and when the Test Recipient’s results become available may be unpredictable. Molecular Matrix, Inc. will provide an estimated time of result availability, but makes no guarantee the results will be provided at that time. Molecular Matrix, Inc. will be communicative about any delays in sample results.

  6. The COVID-19 test is not 100% accurate, cannot be used to rule out an infection, and a negative test does not preclude the presence of COVID-19.

  7. Additional testing may be required depending on the results of the test, including if a result is inconclusive.

 

Test Recipient Requirements

  1. The Test Recipient (or parent/legal guardian) must accurately complete all necessary portions of the Test Requisition Form (also referred to as the Test Registration Form; provided as part of the registration process, usually through the online survey), including providing answers to health questions, medical information, and exposure history.

  2. The Test Recipient must cooperate with Molecular Matrix, Inc. in all matters in regards to COVID-19 testing. Full cooperation during the sample collection process is critical for the safety of the Test Recipient and Molecular Matrix, Inc. personnel.

  3. Test Recipients who are minors aged 17 and under must be accompanied by a parent or legal guardian during the specimen collection procedure.

  4. Test Recipients aged 13 and over are authorized to perform the self-swab specimen collection procedure. A parent or legal guardian must perform the swab specimen collection for Test Recipients aged 12 and under.

  5. The Test Recipient must allow access to the Test Recipient’s physical health information, records, and medical information as may reasonably be requested or required by Molecular Matrix, Inc. for the purposes of performing the COVID-19 Testing.

  6. The Test Recipient must respond to any of Molecular Matrix, Inc.’s requests for additional information, authorizations, or decisions that are reasonably necessary for Molecular Matrix, Inc. to perform COVID-19 Testing Services in accordance with the requirements stated in This Document.

  7. The Test Recipient must provide such Test Recipient materials or information as Molecular Matrix, Inc. may reasonably request to carry out the Testing Services with the provided turnaround time. Test Recipient shall ensure that such Test Recipient materials or information are complete and accurate in all material respects.

  8. The Test Recipient understands and acknowledges that accurate processing of Test Recipient COVID-19 testing is contingent on promptly providing full, complete, and accurate medical information to Molecular Matrix, Inc.

 

Potential Risk and Discomfort

  1. The COVID-19 testing procedure could involve some degree of discomfort, invasiveness, distress, dissatisfaction, and/or other negative reaction. Test Recipient acknowledges this fact, and acknowledges that he/she may experience them as a result of receiving Molecular Matrix, Inc. Covid-19 Testing Services.

  2. The Test Recipient understands, acknowledges, and accepts that any discomfort, invasiveness, distress, and/or other negative reaction is inherent to the testing process and not a result of any misuse of the testing materials by Molecular Matrix, Inc. Test Recipient agrees that Molecular Matrix, Inc. cannot be held liable for any discomfort, invasiveness, distress, and/or other negative reaction experienced by Test Recipient as a part of or result of the COVID-19 Testing Service.

  3. Nothing in This Document shall serve to exempt Molecular Matrix, Inc. and its partners, affiliates, assigns, employees, contractors, and other relevant parties from liability for gross negligence, intentional misconduct, or other liability un-waivable by law.

 

Protecting Test Recipient Privacy

  1. All of the Test Recipient’s confidential information, including medical and financial information, shall be protected in accordance with Health Insurance Portability and Accountability Act (HIPAA) regulations, as well as standard industry practices . Exception may be made for any required disclosures to the Test Recipient’s employer or Federal, State, or Local governments.

  2. Molecular Matrix, Inc. represents and warrants that with respect to all Protected Health Information (PHI), it is a Covered Entity under HIPAA Regulations and that it will protect the confidentiality, privacy, integrity, security, and availability of the PHI disclosed to, used by, or exchanged by the parties.

  3. Test results (Result Reports) are primarily sent with encrypted email or fax, but other methods, including phone or snail mail may also be used upon request by the Test Recipient, or depending on the circumstance.

  4. Molecular Matrix, Inc. will use reasonable means to protect the privacy of the Test Recipient’s PHI, including test results, but the Test Recipient acknowledges the inherent risk of potential disclosure of test results.

  5. The Test Recipient also acknowledges the risks of using certain methods of unencrypted communication, as well as the possibility that someone who has access to the Test Recipient’s devices may be able to access private information.

  6. The Test Recipient consents to Molecular Matrix, Inc. providing their Results Report through encrypted email or fax, and releases Molecular Matrix, Inc. from any liabilities that may arise from the inherent risks in using these methods for the delivery of Result Reports.

Disclosure to Regulatory Bodies and Government Agencies

  1. In the interest of public safety, Federal, State, and Local governments mandate the disclosure of all test results from COVID-19 testing to public authorities.

  2. Test Recipient understands, acknowledges, and agrees that the results of Test Recipient’s COVID19 test administered under This Document is permitted to be disclosed to the applicable Federal, State, and/or Local governments.

  3. Molecular Matrix, Inc. shall not be liable for the applicable Federal, State, or Local governments’ use or misuse of any data, testing results, personal or medical information, or any other information provided as a result of the COVID-19 Testing.

  4. The Test Recipient expressly agrees to waive any applicable HIPAA protections only to the extent necessary to disclose test results to Federal, State, and Local governments.

 

Ownership of Intellectual Property, Confidential Information, and Data

  1. Test Recipient acknowledges and agrees that Molecular Matrix, Inc. shall hold right and title to any intellectual property rights in and to the results of the Testing Services (with identifiable patient information removed) including any derived works or information created from or with the results of the COVID-19 Testing.

 

Disclaimer of Warranties

  1. Except for the representations and warranties expressly set forth in This Document, Molecular Matrix, Inc. makes no representation or guarantee whatsoever regarding the use or misuse of Test Recipient information provided.

  2. Except for the representations and warranties expressly set forth in This Document, Molecular Matrix, Inc. makes no representation or guarantee whatsoever regarding the accuracy of COVID-19 testing results ensuing from improper performance of the self swab or inaccurate Test Recipient information.

 

Limitation of Liability

  1. In no event shall Molecular Matrix, Inc. be liable to the Test Recipient or to any third party for any loss of use, matters regarding employment, pain and suffering, distress, or for any consequential, incidental, indirect, exemplary, special, or punitive damages whether arising out of breach of contract, wrongful conduct, or negligence.

  2. Molecular Matrix, Inc. will take precautions to avoid transmission, spread, or exposure to COVID-19. However, the Test Recipient acknowledges that the risk of potential exposure cannot be fully eliminated. The Test Recipient consents to any reasonable risk of exposure which may arise from the COVID-19 Testing Service procedure.

 

Acknowledgement

 

I authorize Molecular Matrix, Inc. Diagnostic Laboratory (Molecular Matrix) to collect a specimen from me (or my child/dependent named in the Test Requisition) for COVID-19 testing in accordance with this document.

I understand that individuals aged 13 and up are authorized to perform the self-swab specimen collection procedure and individuals aged 12 and under require a parent/legal guardian to perform the swab specimen collection. Minors must be accompanied by a parent/legal guardian during the test procedure.

 

I understand, acknowledge, and accept that I (or my child/dependent) may experience discomfort or other negative reaction as a part of or result of the Covid-19 Testing Service. This discomfort or other negative reaction is inherent to the testing process.

 

I understand, acknowledge, and accept that Molecular Matrix may use email, voicemail, or text message to transmit my test results to me, and I understand the potential risks that may arise.

 

I understand, acknowledge, and accept that Molecular Matrix, Inc. is required to disclose test results to local, state, and/or federal health departments pursuant to applicable laws and regulations.

I understand that I should contact my healthcare provider to discuss the outcomes of this test.

I acknowledge that I have read and understand the Terms and Conditions.

LINKS
CONTACT

Customer Service

1-916-376-9404

info@molecularmatrix.com

3410 Industrial Blvd, Ste 103

West Sacramento, CA 95691

SOCIAL
  • LinkedIn
  • Facebook
  • Instagram_edited
  • Twitter

© 2018 Molecular Matrix, Inc. All rights reserved.